Read more about the under-prescription of first-line treatments for erectile dysfunction in patients with prostate cancer.

Sexual dysfunction post-cancer treatment is underdiscussed, impacting patient and partner quality of life significantly. The EU-ProPER study reveals partners often lack information on treatment ...

There were an estimated 1,926,136 cases of CRC in 2022, marking CRC as one of the most widely encountered cancer types. 1 ICI-based neoadjuvant therapy has shown good therapeutic potential in the past ...

Sexuality and intimate life are integral parts of supportive oncology care. It is important for “oncosexuality” to develop and for intimacy not to be neglected because it is a key driver of quality of ...

The results of the NeuroSAFE PROOF trial, presented at the 2025 European Association of Urology (EAU) Congress in Madrid and published in TheLancet Oncology, raise the prospect of major quality of ...

Results from a phase 3 clinical trial, recently published in The Lancet Oncology, present a significant breakthrough in the field of prostate cancer surgery. The NeuroSAFE technique, a novel approach ...

Use of the erectile dysfunction drug Viagra does not cause the development of melanoma, a deadly form of skin cancer. This is the main finding of new research led by investigators at NYU Langone ...